Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Wu
Mass Retention Efficiencies of He Accretion Onto Carbon-Oxygen White Dwarfs and Type Ia Supernovae
Astronomy and Astrophysics
Astrophysics
Astronomy
Planetary Science
Space
PDB84 Liberalization of Medical Savings Accounts for Outpatient Treatment and Health Care Utilization Among Type 2 Diabetes Mellitus Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
353 Sphingosine 1-Phosphate Receptor 2 (S1PR2) Deficiency Alters Skin Barrier Homeostasis
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
512 Skin Microbiome: Counteraction of Commensal and Pathogenic Staphylococcus Aureus by Glycerol Fermentation
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Science With the Murchison Widefield Array: Phase I Results and Phase II Opportunities – Corrigendum
Publications of the Astronomical Society of Australia
Astrophysics
Astronomy
Planetary Science
Space
Ionospheric Modelling Using GPS to Calibrate the MWA. I: Comparison of First Order Ionospheric Effects Between GPS Models and MWA Observations
Publications of the Astronomical Society of Australia
Astrophysics
Astronomy
Planetary Science
Space
Natural Frequency Optimization of Braided Bistable Carbon/Epoxy Tubes: Analysis of Braid Angles and Stacking Sequences
Composite Structures
Civil
Composites
Structural Engineering
Ceramics
Augment: Relapsed/Refractory Indolent NHL Patients Were More Sensitive to Next Treatment Following Lenalidomide/Rituximab (R2 ) Than Rituximab/Placebo
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Augment Phase Iii Study: Lenalidomide/Rituximab (R2 ) Improved Efficacy Over Rituximab/Placebo in Relapsed/Refractory Follicular Patients Irrespective of Pod24 Status
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN RELAPSED/REFRACTORY (R/R) INDOLENT NHL IN THE PHASE 3 AUGMENT TRIAL OF RITUXIMAB (R) PLUS LENALIDOMIDE (R2 ) VERSUS R PLUS PLACEBO
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
‹
1
2
3
4
5
6
›